Solara board to meet on November 5 for Q2 financial results

Solara Active Pharma Sciences Limited has scheduled a board of directors meeting for Wednesday, November 5, 2025. The primary agenda includes considering and approving the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025.

In adherence to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the company's securities is closed for designated persons. This restriction commenced on October 1, 2025, and will remain in effect for 48 hours following the announcement of the financial results.

The company's communication, dated October 29, 2025, was signed by Pooja Jaya Kumar, company secretary & compliance officer. The notification was sent to both The BSE Limited and The National Stock Exchange of India Limited.